Episode Details

Dario Amodei's call to "pace the frontier" draws public agreement from Sam Altman and Elon Musk, sharp pushback from Armin Ronacher and Yoshua Bengio, and a same-day admission from Altman that OpenAI's own IPO is on hold over safety concerns. A new private-codebase benchmark shows coding agents failing roughly two out of three real enterprise tasks, undercutting the same week's OpenAI-published customer success stories for GPT-6 Astra. And a UPenn antimicrobial-resistance lab shows what AI-as-accelerant actually looks like: faster hypothesis generation, with lab validation and regulatory review as untouched as ever.